During the past decade, Klinikum Augsburg, Medizinische Klinik II conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Augsburg, Medizinische Klinik II" #1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials as a collaborator and "Spectrum Pharmaceuticals, Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Augsburg, Medizinische Klinik II" are "Aggressive Non-hodgkin Lymphoma (aNHL)" (1 trials), "CD20+ Aggressive B-Cell Lymphoma" (1 trials), "Cancer of Unknown Primary Site" (1 trials), "Lymphoma, B-Cell" (1 trials) and "Lymphoma, T-Cell" (1 trials). Many other conditions were trialed in "Klinikum Augsburg, Medizinische Klinik II" in a lesser frequency.

Most popular intervention types in "Klinikum Augsburg, Medizinische Klinik II" are "Drug" (4 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alectinib" (1 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials), "Bone marrow histology" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Augsburg, Medizinische Klinik II" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Augsburg, Medizinische Klinik II". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Klinikum Augsburg, Medizinische Klinik II, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Augsburg, Medizinische Klinik II, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".